488
Participants
Start Date
June 30, 2003
Primary Completion Date
December 31, 2004
Study Completion Date
January 31, 2010
TAXUS Express2
Paclitaxel-Eluting Coronary Stent System
Brachytherapy (beta source)
Brachytherapy (beta source)
Columbia University Medical Center, New York
Lenox Hill Hospital, New York
Albany Medical Center/Capital Cardiovascular Associates, Albany
Buffalo General Hospital, Buffalo
St. Mary's Medical Center, Langhorne
Washington Hospital Center, Washington D.C.
University of Virginia, Charlottesville
Forsyth Medical Center, Winston-Salem
Wake Forest University Health Sciences, Winston-Salem
LeBauer Cardiovascular Research Foundation, Greensboro
Mid-Carolina Cardiology Research Division/Presbyterian Hospital, Charlotte
South Carolina Heart Center, Columbia
Piedmont Hospital, Atlanta
Florida Hospital, Orlando
Baptist Medical Center Princeton, Birmingham
St. Thomas Hospital, Nashville
North Ohio Research, Ltd, Elyria
Cleveland Clinic Foundation, Cleveland
The Lindner Clinical Trial Center, Cincinnati
Spectrum Health Hospitals, Grand Rapids
Cardiac & Vascular Research Center of Northern Michigan, Petoskey
Barnes Jewish Hospital, St Louis
Saint Luke's Hospital, Kansas City
Nebraska Heart Institute, Lincoln
Ochsner Clinic Foundation, New Orleans
Oklahoma Cardiovascular Research Group, Oklahoma City
The Methodist Hospital Research Institute in Cardiovascular Interventions, Houston
South Austin Hospital/Capital Cardiovascular Specialists, Austin
Aurora Denver Cardiology, Aurora
Scripps Green Hospital, La Jolla
Stanford Medical Center, Stanford
Mercy General Hospital, Sacramento
Swedish Medical Center, Seattle
Maine Medical Center, Portland
Washington Adventist Hospital, Takoma Park
Tufts Medical Center, Boston
Lahey Clinic Hospital, Burlington
University of Massachusetts Memorial Medical Center, Worcester
Abbott Northwestern Hospital, Minneapolis
The Miriam Hospital, Providence
Sunnybrook & Women's College Health Sciences Centre, Toronto
Toronto General Hospital, Toronto
Lead Sponsor
Boston Scientific Corporation
INDUSTRY